FR2466020A1 - Reactif et methode pour la determination de l'aldolase du type contenu dans les muscles de l'homme - Google Patents
Reactif et methode pour la determination de l'aldolase du type contenu dans les muscles de l'homme Download PDFInfo
- Publication number
- FR2466020A1 FR2466020A1 FR8020472A FR8020472A FR2466020A1 FR 2466020 A1 FR2466020 A1 FR 2466020A1 FR 8020472 A FR8020472 A FR 8020472A FR 8020472 A FR8020472 A FR 8020472A FR 2466020 A1 FR2466020 A1 FR 2466020A1
- Authority
- FR
- France
- Prior art keywords
- aldolase
- type
- antibody
- muscle
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 title claims abstract description 89
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 title claims abstract description 89
- 210000003205 muscle Anatomy 0.000 title claims abstract description 82
- 238000000034 method Methods 0.000 title claims abstract description 46
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 17
- 241000282414 Homo sapiens Species 0.000 claims abstract description 46
- 102000004190 Enzymes Human genes 0.000 claims abstract description 45
- 108090000790 Enzymes Proteins 0.000 claims abstract description 45
- 101710123627 Fructose-bisphosphate aldolase A Proteins 0.000 claims abstract description 39
- 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 claims abstract description 39
- 239000007790 solid phase Substances 0.000 claims abstract description 16
- 239000000758 substrate Substances 0.000 claims abstract description 14
- 238000000926 separation method Methods 0.000 claims abstract description 6
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 53
- 239000007853 buffer solution Substances 0.000 claims description 20
- 210000002966 serum Anatomy 0.000 claims description 16
- 238000002835 absorbance Methods 0.000 claims description 8
- 230000003387 muscular Effects 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 6
- 238000001042 affinity chromatography Methods 0.000 claims description 5
- HSJKGGMUJITCBW-UHFFFAOYSA-N 3-hydroxybutanal Chemical compound CC(O)CC=O HSJKGGMUJITCBW-UHFFFAOYSA-N 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 claims 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 claims 1
- 229960002478 aldosterone Drugs 0.000 claims 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- FGGVRPFJBBRZFG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCO FGGVRPFJBBRZFG-UHFFFAOYSA-N 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 230000002745 absorbent Effects 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 36
- 238000002474 experimental method Methods 0.000 description 30
- 239000000243 solution Substances 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 17
- 238000003018 immunoassay Methods 0.000 description 11
- 239000000427 antigen Substances 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 102000036639 antigens Human genes 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 6
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 5
- 229920002684 Sepharose Polymers 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- CQTZJAKSNDFPOB-UHFFFAOYSA-N 2-naphthyl dihydrogen phosphate Chemical compound C1=CC=CC2=CC(OP(O)(=O)O)=CC=C21 CQTZJAKSNDFPOB-UHFFFAOYSA-N 0.000 description 1
- 102000003677 Aldehyde-Lyases Human genes 0.000 description 1
- 108090000072 Aldehyde-Lyases Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 1
- 102100034866 Kallikrein-6 Human genes 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- WMDDNKROYKCDJC-UHFFFAOYSA-N [4-[3-oxo-1-(4-phosphonooxyphenyl)-2-benzofuran-1-yl]phenyl] dihydrogen phosphate Chemical compound C1=CC(OP(O)(=O)O)=CC=C1C1(C=2C=CC(OP(O)(O)=O)=CC=2)C2=CC=CC=C2C(=O)O1 WMDDNKROYKCDJC-UHFFFAOYSA-N 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005882 aldol condensation reaction Methods 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- DHCLVCXQIBBOPH-UHFFFAOYSA-N beta-glycerol phosphate Natural products OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 1
- GHRQXJHBXKYCLZ-UHFFFAOYSA-L beta-glycerolphosphate Chemical compound [Na+].[Na+].CC(CO)OOP([O-])([O-])=O GHRQXJHBXKYCLZ-UHFFFAOYSA-L 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12204779A JPS5648894A (en) | 1979-09-25 | 1979-09-25 | Reagent for measuring human muscular aldolase and its determination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2466020A1 true FR2466020A1 (fr) | 1981-03-27 |
| FR2466020B1 FR2466020B1 (it) | 1983-07-08 |
Family
ID=14826285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8020472A Granted FR2466020A1 (fr) | 1979-09-25 | 1980-09-24 | Reactif et methode pour la determination de l'aldolase du type contenu dans les muscles de l'homme |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5648894A (it) |
| BE (1) | BE885376A (it) |
| CA (1) | CA1158549A (it) |
| CH (1) | CH648596A5 (it) |
| DE (1) | DE3036184A1 (it) |
| FR (1) | FR2466020A1 (it) |
| GB (1) | GB2062226B (it) |
| IT (1) | IT1141082B (it) |
| NL (1) | NL8005330A (it) |
| SE (1) | SE447422B (it) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2477573A1 (fr) * | 1980-03-07 | 1981-09-11 | Eisai Co Ltd | Reactif et procede de dosage de l'aldolase musculaire humaine |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57208459A (en) * | 1981-06-19 | 1982-12-21 | Eisai Co Ltd | Measuring method using enzyme-labelled antibody and reagent |
| DE3145936A1 (de) * | 1981-11-20 | 1983-06-01 | Behringwerke Ag, 3550 Marburg | "verfahren zur enzymimmunologischen bestimmung von lipase" |
| JP6754116B2 (ja) * | 2016-04-26 | 2020-09-09 | 学校法人近畿大学 | 大腸癌マーカー |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2141283A5 (it) * | 1971-06-09 | 1973-01-19 | Merck Patent Gmbh | |
| JPS54147097A (en) * | 1978-05-11 | 1979-11-16 | Eisai Co Ltd | Reagent for detecting muscleetype aldolase |
-
1979
- 1979-09-25 JP JP12204779A patent/JPS5648894A/ja active Pending
-
1980
- 1980-09-23 CH CH7209/80A patent/CH648596A5/de not_active IP Right Cessation
- 1980-09-24 CA CA000360973A patent/CA1158549A/en not_active Expired
- 1980-09-24 SE SE8006667A patent/SE447422B/sv not_active IP Right Cessation
- 1980-09-24 NL NL8005330A patent/NL8005330A/nl not_active Application Discontinuation
- 1980-09-24 FR FR8020472A patent/FR2466020A1/fr active Granted
- 1980-09-24 IT IT24877/80A patent/IT1141082B/it active
- 1980-09-24 GB GB8030730A patent/GB2062226B/en not_active Expired
- 1980-09-24 BE BE0/202218A patent/BE885376A/fr not_active IP Right Cessation
- 1980-09-25 DE DE19803036184 patent/DE3036184A1/de not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2141283A5 (it) * | 1971-06-09 | 1973-01-19 | Merck Patent Gmbh | |
| JPS54147097A (en) * | 1978-05-11 | 1979-11-16 | Eisai Co Ltd | Reagent for detecting muscleetype aldolase |
Non-Patent Citations (2)
| Title |
|---|
| CA1978 * |
| CA1980 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2477573A1 (fr) * | 1980-03-07 | 1981-09-11 | Eisai Co Ltd | Reactif et procede de dosage de l'aldolase musculaire humaine |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2466020B1 (it) | 1983-07-08 |
| BE885376A (fr) | 1981-03-24 |
| IT1141082B (it) | 1986-10-01 |
| GB2062226A (en) | 1981-05-20 |
| CH648596A5 (de) | 1985-03-29 |
| JPS5648894A (en) | 1981-05-02 |
| DE3036184A1 (de) | 1981-04-16 |
| CA1158549A (en) | 1983-12-13 |
| IT8024877A0 (it) | 1980-09-24 |
| GB2062226B (en) | 1983-11-30 |
| SE8006667L (sv) | 1981-03-26 |
| NL8005330A (nl) | 1981-03-27 |
| SE447422B (sv) | 1986-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1980002460A1 (fr) | Procede et dispositif pour le dosage des lipoproteines seriques | |
| FR2487983A1 (fr) | Procede d'analyse immunometrique | |
| FR2490826A1 (fr) | Procede pour la mesure de la thyroxine libre ou de la 3,5,3'-triiodothyronine libre dans un echantillon liquide | |
| EP0311492B1 (fr) | Trousse et méthode de dosage immunométrique applicables à des cellules entières | |
| US4001089A (en) | Method for determination of triglycerides and glycerol | |
| CA2633912A1 (fr) | Distinction des meningites bacteriennes et virales | |
| Bucolo et al. | Mechanized enzymatic determination of triglycerides in serum | |
| EP0055751B1 (fr) | Procede de detection et de dosage d'une substance biologique par erythroadsorption | |
| FR2466020A1 (fr) | Reactif et methode pour la determination de l'aldolase du type contenu dans les muscles de l'homme | |
| FR2476320A1 (fr) | Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif | |
| FR2511155A1 (fr) | Detection d'anticorps auto-bloquant | |
| EP0512896B1 (fr) | Complexe agglutinant comme réactif de groupage sanguin | |
| CA2049166A1 (fr) | Procede de dosage d'acide desoxyribonucleique present en position extracellulaire dans un milieu | |
| EP0389381B1 (fr) | Trousse et méthode de dosage enzymatique applicables à des cellules entières | |
| JP4043053B2 (ja) | 生物学上の流体中のプロカルボキシペプチダーゼａおよびカルボキシペプチダーゼａレベルの検出方法 | |
| US4142938A (en) | Determination of triglycerides and glycerol | |
| EP0544578B1 (fr) | Trousse pour le dénombrement rapide des granulocytes et procédé utilisant ladite trousse | |
| FR2531223A1 (fr) | Procede et reactif de dosage immunologique | |
| EP0058539A1 (en) | Enzymatic detection method and use | |
| Kiranas et al. | Enzymatic methods for the determination of α-glycerophosphate and α-glycerophosphate oxidase with an automated FIA system | |
| Lam et al. | Characterization of serum acid phosphatase associated with dengue hemorrhagic fever. | |
| RU2175445C2 (ru) | Среда инкубации для определения активности каталазы в плазме крови | |
| FR2477573A1 (fr) | Reactif et procede de dosage de l'aldolase musculaire humaine | |
| EP0041029A1 (fr) | Procédé et compositions pour le diagnostic in vitro des maladies dues à des déficiences lysozomiales, à des aberrations chromosomiques, à la dystrophie musculaire ou à la fibrose kystique | |
| JPH0677018B2 (ja) | 補体の測定法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |